Item no. |
TRC-N895030-50mg |
Manufacturer |
Toronto Research Chemicals
|
CASRN |
175026-96-7 |
Amount |
50 mg |
Quantity options |
100 mg
10 mg
1 mg
25 mg
50 mg
5 mg
|
Category |
|
Type |
Biochemicals |
Specific against |
other |
InCHI |
1S/C19H13NO4/c1-2-24-19(23)16-15-10-6-3-4-7-11(10)17(21)12-8-5-9-13(14(12)15)20-18(16)22/h3-9H,2H2,1H3,(H,20,22) |
Smiles |
O=C(C(C(NC1=CC=CC2=C31)=O)=C3C4=C(C=CC=C4)C2=O)OCC |
ECLASS 10.1 |
32160490 |
ECLASS 11.0 |
32160490 |
UNSPSC |
12000000 |
Alias |
Ethyl 2,7-Dioxo-3,7-dihydro-2H-naphtho[1,2,3-de]quinoline-1-carboxylate, 2-Hydroxy-7-oxo-7H-naphtho[1,2,3-de]quinoline-1-carboxylic Acid Ethyl Ester, 2,7-Dihydro-2,7-dioxo-3H-naphtho[1,2,3-de]quinoline-1-carboxylic Acid Ethyl Ester |
Shipping condition |
Room temperature |
Hazard information |
Air Forbidden: False | Controlled Products: Not Controlled | UN #: UNCHECK |
Available |
|
Manufacturer - Category |
Apoptosis; Additional Neuro Products; Stress and Anxiety |
Country of Origin |
Canada |
Shipping Temperature |
RT|Room Temperature |
Storage Conditions |
+4°C |
Molecular Weight |
319, 31 |
Air Forbidden |
False |
Controlled Products |
Not Controlled |
MSDS Availability |
TRUE |
UN # |
UNCHECK |
IUPAC |
ethyl 2, 7-dioxo-2, 7-dihydro-3H-naphtho[1, 2, 3-de]quinoline-1-carboxylate |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.